Clinical and pharmacological technologies of personalized medicine: what now and what will happen?
«Omic» biomarkers are promising tools for personalizing pharmacotherapy, including and mental illness because allow predicting an individual profile of the effectiveness and safety of psychotropic drugs. «Omics» biomarkers include pharmacogenomic, pharmacoproteomic, pharmacotranscriptome, pharmacome...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2019-12-01
|
| Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Subjects: | |
| Online Access: | https://www.bekhterevreview.com/jour/article/view/294 |
| Summary: | «Omic» biomarkers are promising tools for personalizing pharmacotherapy, including and mental illness because allow predicting an individual profile of the effectiveness and safety of psychotropic drugs. «Omics» biomarkers include pharmacogenomic, pharmacoproteomic, pharmacotranscriptome, pharmacometabolic biomarkers. A methodology for the development of «omcs» biomarkers of personalization of pharmacotherapy is presented: from assessing the problems of pharmacotherapy to the system of implanting biomarkers into real clinical practice. |
|---|---|
| ISSN: | 2313-7053 2713-055X |